Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

BIOCARTIS ANNOUNCES 2016 HALF-YEAR RESULTS ON 6 SEPTEMBER 2016

BIOCARTIS
Posted on: 30 Aug 16

Mechelen, Belgium, 30 August 2016 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it will report its half-year 2016 results and outlook for the remainder of the year on 6 September 2016 at 07:00h CEST.

The Biocartis management team will host a conference call with live webcast presentation on the day of the results announcement, on 6 September 2016 at 14:00h CEST / 13:00h BST (UK) / 08:00h EDT (US). The live webcast can be accessed here. If you would like to participate in the questions and answers session, please dial in 5-10 minutes prior to the start time using the numbers below and confirmation code 6014209.

Participants, New York, US:                                  +1 646 254 3362

Participants, London, UK:                                     +44 (0)20 3427 1908

Participants, Paris, France:                                     +33 (0)1 76 77 22 28

Participants, Amsterdam, Netherlands:                     +31 (0)20 716 8295

Participants, Brussels, Belgium:                               +32 (0)2 404 0662

The conference call and webcast will be conducted in English. A replay of the webcast will be available on the Biocartis investors website shortly after.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.